Melanie J. Davies - Concepedia

Author

Melanie J. Davies

Also Known As

Albertino Damasceno, C. Kloos, Chun-Chung Chow, D. Davidson, DAVIES, MJ, Davies, M, Davies, M., Davies, M. J., Davies, M.J., Davies, MJ

1.5K

Publications

88.5K

Citations

131

H-Index

363

Concepts

All Affiliations

University of Leicester NIHR Leicester Biomedical Research Centre Leicester General Hospital University Hospitals of Leicester NHS Trust National Institute for Health Research

About

Melanie J. Davies is an author at University of Leicester specializing in medicine, diabetes, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	26	37	3K
2	Engineering	6	6	278
3	Business	3	3	80
4	Education	2	2	42
5	Management	2	2	117

Melanie J. Davies

550

Publications

57.2K

Citations

104

H-Index

Page 1

	Year	Citations
Once-Weekly Semaglutide in Adults with Overweight or Obesity John Wilding, Rachel L. Batterham, Salvatore Calanna, New England Journal of Medicine	2021	3.9K
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Melanie J. Davies, David A. D’Alessio, Judith Fradkin, Diabetes Care	2018	3.4K
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes Juan P. Frías, Melanie J. Davies, Julio Rosenstock, New England Journal of Medicine	2021	1.7K
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Melanie J. Davies, David A. D’Alessio, Judith Fradkin, Diabetologia American Diabetes AssociationMetabolic SyndromeDiabetes ManagementDiabetes EpidemiologyHealth Policy	2018	1.4K
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity Mikhail Kosiborod, Steen Z. Abildstrøm, Barry A. Borlaug, New England Journal of Medicine	2023	1.2K
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Melanie J. Davies, Louise Færch, Ole Kleist Jeppesen, The Lancet ObesityDiabetes ManagementMedicineDiabetesClinical Trials	2021	1.2K
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) John B. Buse, Deborah J. Wexler, Peter Rossing, Diabetes Care Heart FailureAmerican Diabetes AssociationMetabolic SyndromeDiabetes EpidemiologyConsensus Report	2019	1.1K
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity Domenica Rubino, Niclas Abrahamsson, Melanie J. Davies, JAMA	2021	1.1K
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes Melanie J. Davies, Richard M. Bergenstal, Bruce W. Bode, JAMA	2015	1.1K
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity Thomas A. Wadden, Timothy S. Bailey, Liana K. Billings, JAMA	2021	908

Page 1